The opioid epidemic sweeping the U.S. is far costlier than once thought, with the economic impact of the crisis exceeding half a trillion dollars, according to a new report by White House economists.

Massachusetts state Medicaid program hopes to road-test an idea both radical and market-driven: it wants the power to negotiate discounts for the drugs it purchases and to exclude drugs with limited treatment value.

AstraZeneca Plc is in talks to settle a Texas lawsuit claiming that the company fleeced the states Medicaid program by fraudulently marketing one of its top drugs, according to court filings.

Many millennials are comfortable making investment decisions but they'd be even more comfortable getting professional advice.

A robo-advisor alone cannot create trust -- but that's what humans need to feel when investing.

Pew found that 31 percent of private-sector employees it surveyed were not at all familiar with their retirement plan's fees.

The Centers for Medicare and Medicaid will be increasing Medicare Part A premiums $9 per month in 2018, holding the 'standard' Medicare Part B premium steady, and letting the premium many enrollees actually could rise sharply.

As 2017 winds to a close, the benefits tech industry can look back on a year of big lessons.